DR. KIRAN J. PARIKH, M.D.

Plain English
This study looked at what factors affect the chances of survival for lung cancer patients admitted to the intensive care unit (ICU). Out of 528 patients, 58.7% died within 90 days of admission. Key factors influencing mortality included the stage of cancer and overall health, with age and the severity of illness being the strongest predictors after admission. This is important because it helps doctors make better decisions about care for patients with lung cancer in critical situations. Who this helps: This helps doctors and healthcare providers in making informed decisions for lung cancer patients in the ICU.

Plain English
This study looked at how certain viruses contribute to solid tumors and how well new cancer treatments called immune checkpoint inhibitors (ICIs) work on these tumors. Researchers found that viruses are responsible for about 12% to 20% of all cancers globally and that while some patients with virus-related cancers have better survival rates with ICIs, the results are inconsistent. Understanding the link between viruses and cancer is important because it can help improve treatment strategies, especially in regions where these virus-driven cancers are more common. Who this helps: This helps patients with virus-related cancers and their doctors in developing better treatment plans.

Plain English
This research study compared two types of surgical implants used to fix broken bones in the hip, known as intertrochanteric femoral fractures. Researchers analyzed 29 studies involving over 20,000 fractures and found that the integrated dual-lag-screw (IDLS) design resulted in 45% fewer implant-related problems and 63% fewer cases of severe pain compared to the single-lag-screw (SLS) design. This is important because using IDLS nails can lead to better recovery outcomes for patients suffering from these types of fractures. Who this helps: This helps patients, particularly older adults with fragile bones.

Plain English
This study looked at children hospitalized for asthma and how to better support them when transitioning back home. Researchers tested a program where an asthma navigator coordinated care for 12 months after discharge, compared to standard care, to see if it reduced hospital readmissions within a year. They found that this approach could potentially improve ongoing asthma management and quality of life for these children, especially among those at greater risk like Black children and those living in poverty. Who this helps: This helps children with asthma and their families.

Plain English
This study looked at how much fluid is given to patients during major surgeries for gastrointestinal cancer in India, involving 810 patients from 30 hospitals. They found that the average amount of fluid given was about 5.34 milliliters per kilogram per hour, and 7.9% of patients experienced significant complications after surgery. The findings matter because they help set standards for fluid management in surgeries, which can improve recovery and outcomes for patients. Who this helps: Patients undergoing major gastrointestinal cancer surgeries.

Plain English
This study looked at how using powdered vancomycin during orthopedic surgery can lower the chances of infections after surgery. Seven different studies were reviewed, and overall, using vancomycin reduced the risk of surgical site infections by about 51% and specifically cut down the risk of certain types of bacterial infections by 65%. This is important because reducing infections can lead to faster recovery and better outcomes for patients undergoing orthopedic surgery. Who this helps: This benefits patients undergoing orthopedic trauma surgery.

Plain English
This study looked at the usefulness of measuring stroke volume index (SVi), which helps assess heart performance, in children with a condition called pulmonary arterial hypertension (PAH). Researchers found that out of 103 children, those with a lower SVi (33 ml/m or less) experienced complications more frequently, with 38% facing issues like lung transplants or death, compared to only 11% of those with a higher SVi. This is important because it shows that SVi can help doctors identify which patients are at greater risk and may need more intensive care. Who this helps: This helps pediatric patients with pulmonary arterial hypertension and their doctors.

Plain English
This research studied the long-term safety and effectiveness of a specific type of heart stent, called the BioMime Morph sirolimus-eluting stent, used to treat long coronary artery blockages in patients. Out of 448 patients followed for three years, 98.8% remained free from complications related to the stent, and there were only a few occurrences of serious issues, with rates as low as 0.95%. This is important because it shows that this stent is a reliable option for patients with long coronary lesions and may help reduce the chances of needing further procedures. Who this helps: Patients with long coronary artery blockages.

Plain English
This study examined how the neighborhood a child lives in affects their health. Researchers found that children living in areas with low opportunities (indicated by the Child Opportunity Index) had 50% higher odds of dying and were more likely to visit the emergency room for various issues. This is important because it highlights that improving the conditions of neighborhoods can significantly enhance children's health and reduce inequalities. Who this helps: This helps children living in disadvantaged neighborhoods.

Plain English
This research paper reviews the serious complication known as anastomotic leak (AL) that can occur after surgery to remove the esophagus (esophagectomy). It highlights that AL can lead to longer hospital stays and higher risk of death because of factors like existing health issues and the surgical technique used. New methods like special imaging during surgery and new treatment technologies have improved how surgeons prevent and diagnose leaks, leading to better patient outcomes. Who this helps: This helps patients undergoing esophagectomy and their doctors.

Plain English
This study looked at central nervous system (CNS) tumors in children, which are the most common types of solid tumors among kids. It found that tumors like gliomas, medulloblastomas, and ependymomas have different treatments and outcomes: for instance, low-grade gliomas usually have a good survival rate despite often coming back, while high-grade gliomas have poor survival even with aggressive treatment. Understanding the genetic makeup of these tumors helps doctors tailor treatments, leading to better results for many children. Who this helps: This helps patients with pediatric CNS tumors and their families, as well as the doctors treating them.

Plain English
This study looked at how to best manage non-small cell lung cancer (NSCLC) before and after surgery, especially for cases driven by specific gene changes. The researchers found that using targeted treatments like osimertinib for patients with EGFR mutations has become a standard approach, but there are still important questions about how to include other therapies and check for remaining cancer after surgery. Understanding these issues is key to improving treatment options and outcomes for patients with this type of cancer. Who this helps: This helps patients with oncogene-driven non-small cell lung cancer.

Plain English
This study looked at how certain tissue characteristics from surgery in Crohn's disease patients can predict the likelihood of the disease coming back after surgery. Researchers found that 37% of patients had a recurring issue within six months, with 9% experiencing a severe form of this recurrence. They discovered that significant inflammation at the surgery site's margins was a key factor associated with recurrence risk, and combining tissue assessment with clinical information improved prediction accuracy. Who this helps: This helps doctors better predict disease recurrence in Crohn's disease patients after surgery, allowing for more tailored post-operative care.

Plain English
This study looked at a new treatment approach for patients whose lung cancer changed from a common form (NSCLC) to a rarer aggressive type (SCLC). Three patients were treated with a combination of the drugs lurbinectedin and osimertinib, and the results showed that this treatment was safe for them. This is significant because there are currently no established treatments for this transformed type of lung cancer. Who this helps: Patients with transformed SCLC.

Plain English
This study focused on how a health system can better support families with children who have asthma by identifying their social needs, like safe housing and financial support. Researchers implemented a specific checklist to spot these needs across different locations in a pediatric medical center, finding that while families liked the screening, the effectiveness varied by site. They discovered a significant number of families faced unmet social needs, which can worsen asthma problems. Who this helps: This benefits families of children with asthma by connecting them with resources that can improve their health and quality of life.

Plain English
This study looked at recent updates and recommendations for treating pulmonary hypertension in children, especially those born prematurely who may suffer from a related condition called bronchopulmonary dysplasia. The latest guidelines aim to improve how doctors identify and manage this serious condition, which can lead to better long-term health and quality of life for affected children. With these new recommendations, healthcare providers have clearer strategies to help young patients thrive. Who this helps: Patients, especially premature infants with pulmonary hypertension, and their doctors.

Plain English
This study examined the safety and effectiveness of immune checkpoint inhibitors (ICIs) in cancer patients who also have preexisting autoimmune neurological disorders, such as multiple sclerosis (MS) and myasthenia gravis (MG). The researchers analyzed data from 135 patients and found that those with MG experienced significant worsening of their condition, with two patients dying from complications, while MS patients had far fewer issues. Overall, no major differences in cancer treatment outcomes were found between patients with different neurological disorders. Who this helps: This research helps cancer patients with autoimmune neurological disorders and their doctors.

Plain English
This study explored a new gene therapy approach using specialized cells to fight HIV-1, which is the virus that causes AIDS. Researchers created a treatment that combines three strategies: one to stop the virus from entering cells, another to block the virus's action, and a third that targets and destroys infected cells. The enhanced treatment dramatically reduced HIV-1 levels in treated mice, showing a 90% reduction in the virus's presence, and the safety mechanism effectively removed modified cells if needed. Who this helps: This research benefits patients living with HIV by offering a potential long-lasting treatment option.

Plain English
This study looked at how different types of specialized care for children with serious neurological impairments affect their likelihood of needing to return to the hospital shortly after discharge. Researchers found that children discharged from hospitals with a specific type of inpatient care model were less likely to return for further treatment within 14 days (about 31% less likely) and within 30 days. This is important because it suggests that having dedicated care can help improve outcomes for these vulnerable children, reducing the need for additional hospital visits. Who this helps: This benefits children with high-intensity neurologic impairment and their families, as well as healthcare providers involved in their care.

Plain English
The study focuses on the use of regulatory T cells (Tregs) as a potential therapy for patients who have received kidney transplants. Researchers found that Tregs can help manage the body's immune response, reducing the risk of rejection while avoiding the negative effects of long-term use of immunosuppressive drugs. They show promise in improving patient outcomes following transplants. Who this helps: Patients who have undergone kidney transplants.

Plain English
This study focused on how proteins can clump together in biological products, which can affect their stability and cause harmful immune reactions in patients. Researchers found that understanding the different phases of protein aggregation, such as initial lag and rapid growth, is crucial for improving the stability and effectiveness of these therapeutic proteins. Controlling protein aggregation not only enhances treatment quality but also helps reduce costs and improve the availability of safer products. Who this helps: This benefits patients receiving protein-based therapies, as well as doctors who prescribe them.

Plain English
This study reviewed how personalized treatment for patients with a specific type of lung cancer, known as EGFR-mutant non-small cell lung cancer, has improved. Researchers found that new targeted therapies called tyrosine kinase inhibitors (TKIs) lead to longer survival and fewer side effects compared to traditional treatments. However, these advanced treatments can be more expensive and might cause more side effects, so it's essential to choose the right patients for these options based on new tests that measure genetic markers in tumors. Who this helps: This helps patients with EGFR-mutant non-small cell lung cancer by providing more effective and tailored treatment options.

Plain English
This study explored how caregivers perceive the factors that affect asthma health in children under five years old. Researchers interviewed 25 caregivers and 6 asthma care providers, revealing that many caregivers feel uncertain about diagnosing asthma in young children. They identified that practical issues like access to care and knowledge about asthma are crucial, while larger societal factors like racism and policies are often viewed as less relevant. The findings emphasize the need to standardize asthma diagnoses and improve access to care, which could lead to better health outcomes for these children. Who this helps: This benefits young children with asthma and their families.

Plain English
This study focused on an 8-year-old boy with Hodgkin's lymphoma who had a large blood clot in his heart's right atrium, which could be life-threatening. Traditional treatments didn't work well for him, so doctors used a new device called the ŌNŌ to remove the clot safely, successfully reducing its size and the risk of complications. This matters because it offers a new and less invasive treatment option for patients with large blood clots, especially those with other health issues. Who this helps: This helps young patients with blood clots in their hearts.

Plain English
This review studied the use of spray drying to create vaccines that can be inhaled, which could make vaccines easier to deliver and store, especially in areas with limited resources. Inhalable vaccines can directly stimulate the immune system in the lungs, potentially leading to better protection. This method could help overcome some of the challenges associated with traditional vaccines, making it a significant advancement in public health. Who this helps: This benefits patients who need vaccines and healthcare workers who administer them, especially in underserved regions.

Plain English
This research focuses on how the Wnt signaling pathway, which normally helps create blood and immune cells, can go haywire and fuel the growth of acute lymphoblastic leukemia (ALL). The authors found that leukemia stem cells take advantage of this faulty signaling to survive and grow unchecked. By exploring how to target Wnt signaling, they highlight new treatment opportunities that could improve outcomes for patients with ALL. Who this helps: This helps patients with acute lymphoblastic leukemia.

Plain English
This study looked at a rare and aggressive type of lung cancer called pulmonary large cell neuroendocrine carcinoma (LCNEC) in 590 patients. Researchers found that different treatment options—like chemotherapy and immunotherapy—had similar effects on survival, and they identified two main subtypes of LCNEC with specific genetic features. These findings are important because they suggest potential new targets for treatments that could improve outcomes for patients. Who this helps: Patients with pulmonary large cell neuroendocrine carcinoma.

Plain English
This study explored a new type of carbon dot, made from glucose, that can easily cross into the spinal cord and target neurons for imaging. Researchers found that these glucose-based carbon dots (GluCDs) not only successfully reached the spinal cord and parts of the brain within 4 hours, but they also primarily attached to neurons, making them a useful tool for studying spinal injuries and disorders. This is important because it offers a much faster and more effective way to visualize the connections in the spinal cord and potential treatments. Who this helps: Patients with spinal cord injuries and neurological disorders.

Plain English
This study looked at the differences in payments from the medical industry to male and female authors of research articles in leading rheumatology journals. It found that male authors received higher payments and had a greater impact on research, with a significant ratio where male authors earned about 2.5 times more than female authors. As female authors' research impact increased, their payments also grew to match or exceed those of male authors, but overall, males were favored in terms of both payments and recognition in the field. Who this helps: This research benefits patients and advocacy groups working for gender equity in medical research.

Plain English
This study looked at how well two treatment options—immunotherapy alone and immunotherapy combined with chemotherapy—work for lung cancer patients with a specific biomarker called high PD-L1 expression. Researchers found that those who received the combination treatment had an average time before needing more treatment of 11.31 months, compared to 7.63 months for those who had immunotherapy alone. However, both groups had similar overall survival rates, with the chemotherapy group living about 23 months on average and the immunotherapy group about 20 months. This matters because it shows that adding chemotherapy doesn’t improve survival for these patients. Who this helps: This information helps doctors decide on treatment options for patients with high PD-L1 expression lung cancer.

Plain English
This study looked at what people experience before a migraine starts, known as the prodrome phase. Researchers interviewed 20 people with migraines, who reported experiencing an average of 13 symptoms during this time, with the most common being nausea (85%), fatigue (80%), and sensitivity to light (65%). About 40% of these symptoms occurred less than 2 hours before the headache began, meaning that recognizing these early signs could help people start treatment sooner and potentially reduce the severity of their headaches. Who this helps: This helps patients with migraines.

Plain English
This study looked at the link between chronic plaque psoriasis, a common skin disease, and metabolic syndrome, a group of conditions that increase the risk of heart disease and diabetes. Out of 43 patients with psoriasis, 14% (6 patients) also had metabolic syndrome. Those with metabolic syndrome tended to have higher body weight, blood pressure, and unhealthy blood sugar and cholesterol levels compared to those without it, indicating that psoriasis may be connected with other serious health issues. Who this helps: This research is important for patients with psoriasis, as it encourages doctors to screen for related health risks early on.

Plain English
This study looked at a new, smaller flexible tool for a type of kidney surgery in children called retrograde intrarenal surgery (RIRS). The new device is designed to make it easier for doctors to remove kidney stones in kids, and its first use showed promising results. It can greatly improve surgery success while keeping risks low, making it important for treating pediatric patients with kidney stones. Who this helps: This helps children with kidney stones and their doctors.

Plain English
This study looked at different types of BRAF mutations in patients with non-small cell lung cancer (NSCLC) to understand the best treatment options. Researchers found that patients with a specific type of BRAF mutation who were treated with targeted therapies lived longer, averaging 40 months compared to just 10 months for those who didn't receive these treatments. Patients with other BRAF mutations did not show better survival with immune therapies, and the study also revealed that certain mutations come with additional genetic changes that affect treatment response. Who this helps: This research helps patients with non-small cell lung cancer and their doctors in choosing effective treatments based on specific BRAF mutations.

Plain English
The study focused on developing a faster and more environmentally friendly method to create a type of compound (pyrazol-5-ol) that could potentially inhibit a cancer-related protein called EGFR. Researchers used a microwave process with a catalyst made from graphene oxide, achieving yields of up to 95% in just four minutes. One of the compounds they created was particularly effective, showing strong potential to kill human lung cancer cells at a concentration of 15.29 micromolar. Who this helps: This benefits cancer patients by potentially leading to new treatment options.

Plain English
This study looked at a new treatment approach for patients with advanced lung cancer that can't be surgically removed. Researchers found that 93% of the 29 patients responded positively to the initial chemotherapy and immune therapy before receiving further treatment, with a median survival time of 24 months and a median progression-free time of 18 months. This is important because it indicates that this combination therapy might offer a safer and effective option for patients who are not candidates for standard treatments. Who this helps: This helps patients with unresectable stage III lung cancer.

Plain English
This study focused on lorlatinib, a treatment for lung cancer, and how it affects thinking and memory in patients. Out of 63 patients treated, 25 (40%) experienced problems like confusion, memory loss, and hallucinations, with older patients (aged 65 and up) being more at risk—2.6 times more likely to encounter these issues. Additionally, having social support from a partner seemed to reduce the likelihood of hospitalization for these cognitive problems. Who this helps: This research benefits lung cancer patients, especially older ones, as well as their caregivers and healthcare providers.

Plain English
This study looked at how well different systems respond to epidemics in crisis situations, like cholera outbreaks in Yemen and Ebola in the Democratic Republic of the Congo. Researchers reviewed 51 documents and interviewed 28 experts, finding that existing methods often lack coordination and flexibility, leaving local communities and national groups sidelined. They concluded that better integrated and locally tailored response systems are needed, focusing on community needs while ensuring prompt action. Who this helps: This helps patients in humanitarian emergencies by improving epidemic response efforts.

Plain English
This study focused on creating a method to separate proteins from the cytoplasm and nucleus of mammalian cells. The researchers developed a protocol that allows for high-quality collection of these proteins for analysis, which helps to understand how proteins move and function within cells. This is important because it can shed light on how proteins regulate various processes, impacting treatments for diseases related to these functions. Who this helps: This benefits researchers and clinicians studying cellular functions and developing therapies for related diseases.

Plain English
This research paper examines various protein markers that can help diagnose and predict the outcomes of head and neck cancer, especially the most common type, oral squamous cell carcinoma (OSCC). The study highlights that certain biomarkers, including well-known ones like p53 and specific ones like DJ-1, are linked to the development of OSCC and can improve early detection and treatment personalization. The findings indicate that using a combination of these markers could lead to better patient outcomes, as many patients currently face delays in diagnosis. Who this helps: This helps patients with head and neck cancer and their doctors by improving detection and treatment options.

Plain English
This study looked at patients with severe pulmonary hypertension (PH) who also had other heart or lung problems and were treated with a medication called inhaled treprostinil. Out of 270 patients, those who stopped using inhaled treprostinil faced a much higher risk of their condition worsening, with a risk that was over five times greater compared to those who stayed on the treatment. This is important because it highlights the effectiveness of inhaled treprostinil in managing severe PH in real-life situations, even for patients with additional health issues. Who this helps: This benefits patients suffering from severe pulmonary hypertension and their doctors.